Kim, H.I.; Jung, D.H.; Lee, S.J.; Kim, N.; Kim, S.H.; Ji, Y.J.; Byon, H.-J.; Shin, S.K.
Determining ED90 of Flumazenil for Selective Respiratory Distress Improvement Using Remimazolam During Endoscopic Submucosal Dissection of Gastric Neoplasms: A Prospective Study. Cancers 2025, 17, 321.
https://doi.org/10.3390/cancers17020321
AMA Style
Kim HI, Jung DH, Lee SJ, Kim N, Kim SH, Ji YJ, Byon H-J, Shin SK.
Determining ED90 of Flumazenil for Selective Respiratory Distress Improvement Using Remimazolam During Endoscopic Submucosal Dissection of Gastric Neoplasms: A Prospective Study. Cancers. 2025; 17(2):321.
https://doi.org/10.3390/cancers17020321
Chicago/Turabian Style
Kim, Hyun Il, Da Hyun Jung, Sung Jin Lee, Namo Kim, Seung Hyun Kim, Yu Jun Ji, Hyo-Jin Byon, and Sung Kwan Shin.
2025. "Determining ED90 of Flumazenil for Selective Respiratory Distress Improvement Using Remimazolam During Endoscopic Submucosal Dissection of Gastric Neoplasms: A Prospective Study" Cancers 17, no. 2: 321.
https://doi.org/10.3390/cancers17020321
APA Style
Kim, H. I., Jung, D. H., Lee, S. J., Kim, N., Kim, S. H., Ji, Y. J., Byon, H.-J., & Shin, S. K.
(2025). Determining ED90 of Flumazenil for Selective Respiratory Distress Improvement Using Remimazolam During Endoscopic Submucosal Dissection of Gastric Neoplasms: A Prospective Study. Cancers, 17(2), 321.
https://doi.org/10.3390/cancers17020321
